Good decisions require good information
Find hidden gems and smart strategies from top experts when you join Seeking Alpha.
RHHBY Roche Holding AGStock Price & Overview
$34.67
Charts
Quant Ranking
RHHBY Analysis
RHHBY News
Latest Headlines
Ratings Summary
People Also Follow
Similar to RHHBY
ETFs Holding RHHBY
RHHBY Company Profile
Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and Oceania. The company offers pharmaceutical products in the therapeutic areas of anemia, blood and solid tumors, dermatology, hemophilia, inflammatory and autoimmune, neurological disorders, ophthalmology, respiratory disorders, and transplantation. It is also developing products for various therapeutic areas. In addition, it offers in vitro tests for the diagnosis of various diseases, such as cancer, diabetes, Covid-19, hepatitis, human papillomavirus, and other diseases; diagnostic instruments; and digital health solutions. Roche Holding AG was founded in 1896 and is based in Basel, Switzerland.
RHHBY Revenue
RHHBY Earnings Per Share
Earnings Estimates
Earnings Revisions
Valuation
Growth
Profitability
Momentum
Capital Structure
RHHBY Dividend Growth History
RHHBY Ownership
RHHBY Peers
Risk
Technicals
RHHBY Transcripts
Investor Presentations
RHHBY SEC Filings
Press Releases
RHHBY Income Statement
RHHBY Balance Sheet
RHHBY Cash Flow Statement
RHHBY Long Term Solvency
Discover More
You may be interested in: